沃华医药：实际控制人拟由赵丙贤变为无实际控制人

Core Viewpoint - The recent court ruling regarding the divorce property dispute between Zhao Bingxian and Lu Juan has resulted in a significant change in the actual control of Wohuah Pharmaceutical, as the ownership of the controlling shareholder, Zhongzheng Wanrong Investment Group, is now equally divided between the two parties, leading to the absence of a single actual controller [1]. Group 1 - Wohuah Pharmaceutical announced that the Beijing Third Intermediate People's Court upheld the first-instance ruling regarding the division of shares in Zhongzheng Wanrong Investment Group, ordering an equal split of the shares between Zhao Bingxian and Lu Juan [1]. - Following the court's decision, both Zhao Bingxian and Lu Juan now hold 50% of Zhongzheng Wanrong Investment Group, which in turn holds 50.27% of Wohuah Pharmaceutical, maintaining the group's status as the controlling shareholder [1]. - The ruling has immediate effect, resulting in a change of actual control from Zhao Bingxian to a situation where there is no single actual controller, as neither party can independently control Zhongzheng Wanrong Investment Group [1]. Group 2 - Despite the change in actual control, Zhao Bingxian continues to serve as the chairman, legal representative, and president of Zhongzheng Wanrong Investment Group, as well as the chairman and legal representative of Wohuah Pharmaceutical, and all business operations remain unaffected [1].